Literature DB >> 7509388

Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase.

S Z Wang1, S Z Zhu, E E el-Fakahany.   

Abstract

The coupling of m5 muscarinic acetylcholine receptors to the generation and release of nitric oxide (NO) was investigated. Chinese hamster ovary cells, which stably express m5 receptors, were transiently transfected with the gene encoding neuronal NO synthase and used as a model system. Increased generation of NO upon stimulation of cells by muscarinic agonists was detected by an increase in cyclic GMP in admixed mouse neuroblastoma N1E-115 cells or more directly by measuring the conversion of L-arginine into L-citrulline. Carbachol increased cyclic GMP formation in the mixture of cells in a time- and concentration-dependent manner, with a half-maximal response occurring in the nanomolar range. This response was significantly attenuated by scavengers of NO or inhibitors of NO synthase. This high potency of carbachol was also observed in measurements of L-citrulline formation. A series of muscarinic agonists were as efficacious as carbachol in stimulating NO synthase, whereas McN-A-343 and pilocarpine were partial agonists in this regard. Evidence for an exceptionally high efficiency of coupling of m5 receptors to this response and its possible implication in the interaction between cholinergic and dopaminergic neurotransmission is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509388

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  The muscarinic M(5) receptor: a silent or emerging subtype?

Authors:  R M Eglen; S R Nahorski
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice.

Authors:  M Yamada; K G Lamping; A Duttaroy; W Zhang; Y Cui; F P Bymaster; D L McKinzie; C C Felder; C X Deng; F M Faraci; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

3.  Upregulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses.

Authors:  Takeshi Fujii; Yoshihiro Watanabe; Tomoyuki Inoue; Koichiro Kawashima
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 4.  Racial differences in nitric oxide-dependent vasorelaxation.

Authors:  Eugenia Mata-Greenwood; Dong-Bao Chen
Journal:  Reprod Sci       Date:  2008-01       Impact factor: 3.060

5.  Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels.

Authors:  D G Linville; E Hamel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

6.  Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome.

Authors:  Julian M Stewart; Marvin S Medow; Christopher T Minson; Indu Taneja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-27       Impact factor: 4.733

Review 7.  Alcohol and the brain: what's NO got to do with it?

Authors:  F E Lancaster
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

8.  On the effect of minocycline on the depressive-like behavior of mice repeatedly exposed to malathion: interaction between nitric oxide and cholinergic system.

Authors:  Seyed Soheil Saeedi Saravi; Roya Amirkhanloo; Alireza Arefidoust; Rahele Yaftian; Seyed Sobhan Saeedi Saravi; Mohammad Shokrzadeh; Ahmad Reza Dehpour
Journal:  Metab Brain Dis       Date:  2015-11-19       Impact factor: 3.584

9.  Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency.

Authors:  Naohito Kitamura; Runa Araya; Moeko Kudoh; Haruo Kishida; Tetsuya Kimura; Miyuki Murayama; Akihiko Takashima; Yuriko Sakamaki; Tsutomu Hashikawa; Shingo Ito; Sumio Ohtsuki; Tetsuya Terasaki; Jürgen Wess; Masahisa Yamada
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.